Roger Wilson

Roger was diagnosed with a soft tissue sarcoma in 1999. Three years after his diagnosis, Roger and his wife, Sheelagh started work on what has now become Sarcoma UK. 

In 2016, the charity launched the Roger Wilson Research Award, which will form part of the annual Clinical Research Call and each year will have a different focus on a specific area of research. 

In 2016 the theme of the Roger Wilson Research Award was “Quality of Life”, and the following research projects were funded:  

Development of a sarcoma-specific patient-reported outcome measure S-PROM 

Can a holistic model of rehabilitation improve quality of life after treatment for lower extremity sarcoma? A pilot and feasibility study 

In 2017 the theme of the Roger Wilson Research Award was “Early Diagnosis”, the following research project was funded:  

Exploring socio-demographic inequalities in the diagnosis of sarcoma, with a particular focus on deprivation

The 2018 theme was "Research which benefits patients at the point of treatment and beyond".

The diagnostic experince of sarcoma patients

The 2019  call asked for applications which addressed one or more of the National Cancer Research Institute's "Living with and beyond cancer" priority research questions.

Managing the fear of sarcoma returning 

2020's Roger Wilson Research Award went to the international STRASS II clinical trial, which is exploring treatments for retroperitoneal sarcoma.

EORTC STRASS II Trial: An international clinical trial exploring treatment options for retroperitoneal sarcoma patients

Sarcoma UK is member charity of AMRC. All research funded by Sarcoma UK is eligible for QR funding via the CRSF.